Physician profile
Anthony Cifelli
NPI 1245228451
$3,073.98
in general payments reported to CMS, 2019-2025
22 companies · $513 in 2025
The $513 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $209 · 2021: $876 · 2022: $211 · 2023: $395 · 2024: $503 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,391 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,391.31 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $807.30 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $566.76 | 2020-2025 | Ozempic |
| Abbvie INC. | $527.11 | 2019-2025 | Qulipta, Ubrelvy, Vraylar |
| Biohaven Pharmaceuticals, INC. | $216.27 | 2021 | |
| Allergan, INC. | $200.30 | 2019-2020 | |
| Amarin Pharma, INC. | $152.53 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $120.30 | 2023 | Quviviq |
| Kowa Pharmaceuticals America, INC. | $119.82 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $82.09 | 2020-2021 | |
| Almatica Pharma LLC | $43.46 | 2022 | |
| Janssen Pharmaceuticals, INC | $38.85 | 2019 | |
| Pfizer INC. | $32.25 | 2020-2022 | |
| Hikma Pharmaceuticals USA | $29.05 | 2021-2022 | |
| Glaxosmithkline, LLC. | $24.66 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.62 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $15.74 | 2025 | Gemtesa |
| Eyevance Pharmaceuticals LLC | $14.05 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.05 | 2021 | |
| Abbott Laboratories | $13.67 | 2022 | |
| Horizon Therapeutics Plc | $12.86 | 2019 | |
| Leo Pharma INC. | $12.86 | 2019 | |
| Althera Pharmaceuticals LLC | $10.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Cifelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.